View in browser


Pharmaceutical Technology

 
Share this newsletter with a friend or colleague
 
Sanofi reports 12.4% sales growth in Q2 2021
image_alt

The company revised the full-year 2021 business EPS guidance, increasing it by approximately 12%.


Features

FDA hits milestone with approval of first interchangeable insulin biosimilar
The FDA’s designation of Semglee as interchangeable with Sanofi’s Lantus represents a key milestone for US biosimilars.

China’s tech future depends on children and surveillance
A bountiful tech industry means the children of China face a prosperous future. The same tech is watching them, and ever evolving, as Giacomo Lee discovers.

Calico and AbbVie: Google-backed partnership re-commits to anti-ageing mission
Calico entered a partnership with global biopharma AbbVie to uncover and market novel treatments for age-related diseases in 2014.


Projects

Charnwood Campus’ Building 42 Research Facility Modernisation, Loughborough, UK
The Charnwood Campus is a life sciences technology park located in Loughborough, UK, which accommodates global MedTech and biopharma companies to promote their business growth.

SHINE Medical Isotope Production Facility, Veendam, Netherlands
US-based radiopharmaceutical company SHINE Medical Technologies is to build a medical isotope production facility in Veendam, Netherlands. The facility is intended to provide a reliable, flexible supply of a range of vital medical tracers and cancer treatment elements for customers in Europe.

AbCellera Biologics’ GMP Manufacturing Facility, Vancouver, Canada
Canadian biotechnology firm AbCellera Biologics is to build a good manufacturing practice (GMP) antibody manufacturing facility in Vancouver.


Event
Pharma and Patient USA

2 Nov - 4 Nov

Virtual   |  Organiser: reutersevents.com

+ ADD TO MY CALENDAR

From our partners


Press Releases

New Book Launch: Digital Transformation of the Laboratory, Wiley Inc
“Digital Transformation of the Laboratory: A Practical Guide to the Connected Lab delivers essential and transformative new insights into current and future technologies and strategies for the digitization of laboratories. Thoroughly supported and backed-up with contributions from thought and industry leaders, the book shows scientists in industry and academia how to move from paper to digital in their own labs.”- Wiley Inc.

METO Systems to Display New Products and Hold Live Demos at This Year’s IPBS
Join Us at The Powder Show, Live and in Person. This year’s event will be held at the Donald E. Stevens Convention Center in Rosemont, IL.

LC Versus LC Light Series – Highly Specialised or Perfected Coaters for Standard Applications
With coaters from the LC and LC light series, Lödige Process Technology offers two different machine concepts for the film coating of tablets. Pharmaceutical companies have a choice when looking for the optimum task-specific solution. Systems can thus be realised that precisely meet the respective requirements.


Whitepapers

Covid-19 in Pharma: Deal trends Q1 2019 to Q1 2021
Are you considering the relevance of Covid-19 to your business? GlobalData’s report can help you understand the bigger picture by analyzing Covid-19-related filing trends across the Pharma sector in 2021. Uncover overarching company sentiment and underlying patterns hidden in vast amounts of financial and non-financial data to get a grasp on the outlook for the technology theme and its evolution in view of major market events like COVID-19. Read the report to see how Covid-19 can help drive your business forward today.

Sartorius Extractables Simulator: Simplifying E&L Through In-Silico Modelling
Sartorius has implemented specialized algorithms for the scaling and combination phases based on physical principles rather than intuitive and empirical procedures. We describe the conceptualization of a database and software application, the Extractables Simulator (ExSim).

Customer Case Study – Protein a Resin Reduction Achieved with Process Transfer from Batch to BioSMB
Sanofi’s key driver for this study was to reduce the operating costs of existing purification steps with high resin costs. Regulatory concerns were to be tested by determining product quality consistency through process transfer and scale-up. The feasibility of extended purifications at production scale was also determined by evaluating BioSMB system robustness.

Thanks for reading. If you enjoyed this newsletter, please share with colleagues, friends and anybody else, get them to sign up and join the conversation. You can contact us at marketing@verdict.co.uk.

Pharmaceutical Technology